HOYA Corporation (HOCPY)
USD 113.96
(0.62%)
USD 113.96
(0.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 181.37 Billion JPY | 7.55% |
| 2022 | 168.63 Billion JPY | 2.51% |
| 2021 | 164.5 Billion JPY | 31.14% |
| 2020 | 125.44 Billion JPY | 9.65% |
| 2019 | 114.4 Billion JPY | -6.3% |
| 2018 | 122.1 Billion JPY | 22.72% |
| 2017 | 99.49 Billion JPY | 14.7% |
| 2016 | 86.74 Billion JPY | -6.91% |
| 2015 | 93.17 Billion JPY | 0.4% |
| 2014 | 92.8 Billion JPY | 58.94% |
| 2013 | 58.39 Billion JPY | -17.88% |
| 2012 | 71.09 Billion JPY | 64.51% |
| 2011 | 43.21 Billion JPY | -27.66% |
| 2010 | 59.74 Billion JPY | 57.74% |
| 2009 | 37.87 Billion JPY | 50.84% |
| 2008 | 25.11 Billion JPY | -69.28% |
| 2007 | 81.72 Billion JPY | -2.0% |
| 2006 | 83.39 Billion JPY | 10.28% |
| 2005 | 75.62 Billion JPY | 17.91% |
| 2004 | 64.13 Billion JPY | 62.17% |
| 2003 | 39.54 Billion JPY | 97.37% |
| 2002 | 20.03 Billion JPY | -15.6% |
| 2001 | 23.74 Billion JPY | 8.6% |
| 2000 | 21.86 Billion JPY | 5.52% |
| 1999 | 20.71 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 47.15 Billion JPY | -16.22% |
| 2023 Q2 | 47.71 Billion JPY | 24.84% |
| 2023 Q4 | 56.28 Billion JPY | 44.38% |
| 2023 FY | 181.37 Billion JPY | 7.55% |
| 2023 Q1 | 38.21 Billion JPY | -10.19% |
| 2023 Q3 | 38.98 Billion JPY | -18.29% |
| 2022 FY | 168.63 Billion JPY | 2.51% |
| 2022 Q1 | 48.35 Billion JPY | 22.67% |
| 2022 Q2 | 47.1 Billion JPY | -2.6% |
| 2022 Q3 | 30.53 Billion JPY | -35.16% |
| 2022 Q4 | 42.55 Billion JPY | 39.35% |
| 2021 Q1 | 41.25 Billion JPY | 33.01% |
| 2021 Q3 | 40.86 Billion JPY | -4.9% |
| 2021 Q4 | 39.42 Billion JPY | -3.52% |
| 2021 FY | 164.5 Billion JPY | 31.14% |
| 2021 Q2 | 42.96 Billion JPY | 4.14% |
| 2020 Q1 | 25.88 Billion JPY | 29.74% |
| 2020 Q3 | 36.69 Billion JPY | 15.23% |
| 2020 Q4 | 31.01 Billion JPY | -15.48% |
| 2020 FY | 125.44 Billion JPY | 9.65% |
| 2020 Q2 | 31.84 Billion JPY | 23.04% |
| 2019 Q1 | 30.04 Billion JPY | 3.24% |
| 2019 Q2 | 34.86 Billion JPY | 16.05% |
| 2019 Q3 | 29.54 Billion JPY | -15.27% |
| 2019 Q4 | 19.95 Billion JPY | -32.47% |
| 2019 FY | 114.4 Billion JPY | -6.3% |
| 2018 Q3 | 33.16 Billion JPY | 5.84% |
| 2018 Q1 | 28.49 Billion JPY | 47.07% |
| 2018 Q2 | 31.33 Billion JPY | 9.98% |
| 2018 Q4 | 29.1 Billion JPY | -12.24% |
| 2018 FY | 122.1 Billion JPY | 22.72% |
| 2017 Q2 | 27.16 Billion JPY | 8.15% |
| 2017 FY | 99.49 Billion JPY | 14.7% |
| 2017 Q4 | 19.37 Billion JPY | -30.41% |
| 2017 Q1 | 25.11 Billion JPY | 32.75% |
| 2017 Q3 | 27.83 Billion JPY | 2.47% |
| 2016 Q1 | 17.9 Billion JPY | -4.41% |
| 2016 Q2 | 24.85 Billion JPY | 38.79% |
| 2016 Q3 | 25.05 Billion JPY | 0.8% |
| 2016 FY | 86.74 Billion JPY | -6.91% |
| 2016 Q4 | 18.92 Billion JPY | -24.48% |
| 2015 Q2 | 27.03 Billion JPY | 15.82% |
| 2015 FY | 93.17 Billion JPY | 0.4% |
| 2015 Q4 | 18.73 Billion JPY | -22.14% |
| 2015 Q3 | 24.06 Billion JPY | -11.01% |
| 2015 Q1 | 23.34 Billion JPY | 23.16% |
| 2014 Q1 | 17.79 Billion JPY | 39.84% |
| 2014 Q2 | 27.15 Billion JPY | 52.55% |
| 2014 FY | 92.8 Billion JPY | 58.94% |
| 2014 Q3 | 28.9 Billion JPY | 6.46% |
| 2014 Q4 | 18.95 Billion JPY | -34.42% |
| 2013 FY | 58.39 Billion JPY | -17.88% |
| 2013 Q4 | 12.72 Billion JPY | -38.31% |
| 2013 Q3 | 20.63 Billion JPY | 62.09% |
| 2013 Q2 | 12.72 Billion JPY | 3.48% |
| 2013 Q1 | 12.3 Billion JPY | -46.97% |
| 2012 Q4 | 23.19 Billion JPY | 125.36% |
| 2012 Q1 | 23.17 Billion JPY | 90.97% |
| 2012 FY | 71.09 Billion JPY | 64.51% |
| 2012 Q2 | 12.52 Billion JPY | -45.97% |
| 2012 Q3 | 10.29 Billion JPY | -17.81% |
| 2011 FY | 43.21 Billion JPY | -27.66% |
| 2011 Q1 | 15.31 Billion JPY | 74.77% |
| 2011 Q2 | 12.52 Billion JPY | -18.21% |
| 2011 Q3 | 3.24 Billion JPY | -74.08% |
| 2011 Q4 | 12.13 Billion JPY | 273.91% |
| 2010 Q1 | 21.02 Billion JPY | 76.95% |
| 2010 FY | 59.74 Billion JPY | 57.74% |
| 2010 Q4 | 8.76 Billion JPY | -33.68% |
| 2010 Q3 | 13.21 Billion JPY | 2.47% |
| 2010 Q2 | 12.89 Billion JPY | -38.69% |
| 2009 FY | 37.87 Billion JPY | 50.84% |
| 2009 Q4 | 11.88 Billion JPY | 0.77% |
| 2009 Q3 | 11.79 Billion JPY | 13.91% |
| 2009 Q2 | 10.35 Billion JPY | 168.86% |
| 2009 Q1 | 3.85 Billion JPY | 113.83% |
| 2008 Q4 | -27.83 Billion JPY | -320.73% |
| 2008 Q3 | 12.61 Billion JPY | -34.1% |
| 2008 Q2 | 19.13 Billion JPY | -9.73% |
| 2008 Q1 | 21.19 Billion JPY | 0.92% |
| 2008 FY | 25.11 Billion JPY | -69.28% |
| 2007 Q4 | 21 Billion JPY | -7.07% |
| 2007 Q3 | 22.6 Billion JPY | 7.53% |
| 2007 Q1 | 17.09 Billion JPY | 0.0% |
| 2007 Q2 | 21.02 Billion JPY | 22.95% |
| 2007 FY | 81.72 Billion JPY | -2.0% |
| 2006 FY | 83.39 Billion JPY | 10.28% |
| 2005 FY | 75.62 Billion JPY | 17.91% |
| 2004 FY | 64.13 Billion JPY | 62.17% |
| 2003 FY | 39.54 Billion JPY | 97.37% |
| 2002 FY | 20.03 Billion JPY | -15.6% |
| 2001 FY | 23.74 Billion JPY | 8.6% |
| 2000 FY | 21.86 Billion JPY | 5.52% |
| 1999 FY | 20.71 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 19568270.22% |
| Ansell Limited | 76.5 Million USD | -236992.81% |
| Ansell Limited | 76.5 Million USD | -236992.81% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -746911.969% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 11125803.346% |
| Psykey, Inc. | -1.32 Million USD | 13699700.665% |
| ConvaTec Group Plc | 130.3 Million USD | -139098.772% |
| ConvaTec Group Plc | 130.3 Million USD | -139098.772% |
| Encision Inc. | -691.78 Thousand USD | 26218726.361% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 127899910.311% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 77390165.112% |
| Innovative MedTech Inc. | -7.93 Million USD | 2284749.87% |
| LifePoint, Inc. | -15.23 Million USD | 1190887.808% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 2663086.346% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 38265078.903% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 66088146.465% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 39513158.027% |
| SmileDirectClub, Inc. | -86.4 Million USD | 210016.208% |
| Sector 10, Inc. | 7036.00 USD | -2577828211.541% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | -8960.166% |
| SheerVision, Inc. | -71.37 Thousand USD | 254113527.483% |
| United Health Products, Inc. | -2.62 Million USD | 6914226.545% |
| Vasamed, Inc. | -4.88 Million USD | 3710622.154% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 7593924.826% |
| Yubo International Biotech Limited | -1.2 Million USD | 15054986.223% |